v3.25.2
Segments of Business and Geographic Areas - Operating Profit by Segment of Business (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 29, 2025
Mar. 30, 2025
Jun. 30, 2024
Jun. 29, 2025
Jun. 30, 2024
Segment Reporting Information [Line Items]          
Sales to customers (Note 9) $ 23,743   $ 22,447 $ 45,636 $ 43,830
Cost of products sold 7,628   6,869 14,985 13,380
Gross Profit 16,115   15,578 30,651 30,450
Selling, marketing and administrative expenses 5,889   5,681 11,001 10,938
Research and development expense 3,516   3,440 6,741 6,982
Other (income) expense, net (107)   (653) 7,214 (3,057)
Earnings before provision for taxes on income 6,491   5,748 20,122 9,462
Less: Expense not allocated to segments 265   800 (6,735) 3,575
Restructuring charges 64   (13) 81 151
Acquisition related costs 200        
Innovative Medicine          
Segment Reporting Information [Line Items]          
Sales to customers (Note 9) 15,202   14,490 29,075 28,052
Restructuring charges         100
Impairment of intangible assets, finite-lived     200   200
Restructuring income     100    
Acquisition related costs       200  
MedTech          
Segment Reporting Information [Line Items]          
Sales to customers (Note 9) 8,541   7,957 16,561 15,778
Restructuring charges 100   100 100 100
Acquisition related costs     400 100 500
Consumer | Talc          
Segment Reporting Information [Line Items]          
Litigation expense     300   3,000
Reversal of fee expense   $ 7,000   7,000  
Operating Segments          
Segment Reporting Information [Line Items]          
Earnings before provision for taxes on income 6,756   6,548 13,387 13,037
Restructuring charges 79   (11) 134 160
Operating Segments | Innovative Medicine          
Segment Reporting Information [Line Items]          
Sales to customers (Note 9) 15,202   14,490 29,075 28,052
Cost of products sold 3,978   3,603 7,998 6,973
Selling, marketing and administrative expenses 2,789   2,665 5,050 5,103
Research and development expense 2,869   2,722 5,417 5,618
Other (income) expense, net 14   41 (152) (70)
Earnings before provision for taxes on income 5,552   5,459 10,762 10,428
Amortization 800   700 1,400 1,400
Restructuring charges 0   (63) 0 81
Operating Segments | MedTech          
Segment Reporting Information [Line Items]          
Sales to customers (Note 9) 8,541   7,957 16,561 15,778
Cost of products sold 3,638   3,248 6,964 6,368
Selling, marketing and administrative expenses 2,862   2,671 5,518 5,253
Research and development expense 647   718 1,324 1,364
Other (income) expense, net 190   231 130 184
Earnings before provision for taxes on income 1,204   1,089 2,625 2,609
Amortization 500   400 1,000 800
Restructuring charges $ 50   $ 52 $ 105 $ 79